N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide

C76H79N17O8 — CID 158894627

IUPACN-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide
SMILESCc1nc(-c2ccc(Cc3cc(C(=O)N[C@H]4CCCC[C@@H]4O)nc(-n4cccn4)c3)cc2)co1.Cc1nc(-c2ccc(Cc3cc(C(=O)N[C@H]4CCC[C@@H]4O)nc(-n4cccn4)c3)cc2)co1.Cn1cc(-c2ccc(Cc3cc(C(=O)N[C@H]4CCCC[C@@H]4O)nc(-n4cccn4)c3)cn2)cn1
InChIInChI=1S/C26H27N5O3.C25H27N7O2.C25H25N5O3/c1-17-28-23(16-34-17)20-9-7-18(8-10-20)13-19-14-22(29-25(15-19)31-12-4-11-27-31)26(33)30-21-5-2-3-6-24(21)32;1-31-16-19(15-28-31)20-8-7-17(14-26-20)11-18-12-22(29-24(13-18)32-10-4-9-27-32)25(34)30-21-5-2-3-6-23(21)33;1-16-27-22(15-33-16)19-8-6-17(7-9-19)12-18-13-21(25(32)29-20-4-2-5-23(20)31)28-24(14-18)30-11-3-10-26-30/h4,7-12,14-16,21,24,32H,2-3,5-6,13H2,1H3,(H,30,33);4,7-10,12-16,21,23,33H,2-3,5-6,11H2,1H3,(H,30,34);3,6-11,13-15,20,23,31H,2,4-5,12H2,1H3,(H,29,32)/t21-,24-;21-,23-;20-,23-/m000/s1
InChIKeyJERHTSAHCNMPJH-OAJLFASKSA-N
MW1358.58 g/mol
LogP10.01
Rot. Bonds18

About N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide

N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide (PubChem CID 158894627) has the molecular formula C76H79N17O8 and a molecular weight of 1358.58 g/mol. Its IUPAC name is N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide.

Molecular Properties

Compound NameN-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide
PubChem CID158894627
Molecular FormulaC76H79N17O8
Molecular Weight1358.58 g/mol
Exact Mass1357.63
IUPAC NameN-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide
SMILESCc1nc(-c2ccc(Cc3cc(C(=O)N[C@H]4CCCC[C@@H]4O)nc(-n4cccn4)c3)cc2)co1.Cc1nc(-c2ccc(Cc3cc(C(=O)N[C@H]4CCC[C@@H]4O)nc(-n4cccn4)c3)cc2)co1.Cn1cc(-c2ccc(Cc3cc(C(=O)N[C@H]4CCCC[C@@H]4O)nc(-n4cccn4)c3)cn2)cn1
InChIInChI=1S/C26H27N5O3.C25H27N7O2.C25H25N5O3/c1-17-28-23(16-34-17)20-9-7-18(8-10-20)13-19-14-22(29-25(15-19)31-12-4-11-27-31)26(33)30-21-5-2-3-6-24(21)32;1-31-16-19(15-28-31)20-8-7-17(14-26-20)11-18-12-22(29-24(13-18)32-10-4-9-27-32)25(34)30-21-5-2-3-6-23(21)33;1-16-27-22(15-33-16)19-8-6-17(7-9-19)12-18-13-21(25(32)29-20-4-2-5-23(20)31)28-24(14-18)30-11-3-10-26-30/h4,7-12,14-16,21,24,32H,2-3,5-6,13H2,1H3,(H,30,33);4,7-10,12-16,21,23,33H,2-3,5-6,11H2,1H3,(H,30,34);3,6-11,13-15,20,23,31H,2,4-5,12H2,1H3,(H,29,32)/t21-,24-;21-,23-;20-,23-/m000/s1
InChIKeyJERHTSAHCNMPJH-OAJLFASKSA-N
XLogP10.01
TPSA322.89 Ų
H-Bond Donors6
H-Bond Acceptors22
Rotatable Bonds18
Heavy Atoms101
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001358.58
LogP ≤ 510.01
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1022

Analyze N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide?
The IUPAC name of N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide (CID 158894627) is N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide.
What is the SMILES notation for N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide?
The canonical SMILES for N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide is Cc1nc(-c2ccc(Cc3cc(C(=O)N[C@H]4CCCC[C@@H]4O)nc(-n4cccn4)c3)cc2)co1.Cc1nc(-c2ccc(Cc3cc(C(=O)N[C@H]4CCC[C@@H]4O)nc(-n4cccn4)c3)cc2)co1.Cn1cc(-c2ccc(Cc3cc(C(=O)N[C@H]4CCCC[C@@H]4O)nc(-n4cccn4)c3)cn2)cn1.
What is the InChIKey of N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide?
The InChIKey is JERHTSAHCNMPJH-OAJLFASKSA-N. The full InChI is InChI=1S/C26H27N5O3.C25H27N7O2.C25H25N5O3/c1-17-28-23(16-34-17)20-9-7-18(8-10-20)13-19-14-22(29-25(15-19)31-12-4-11-27-31)26(33)30-21-5-2-3-6-24(21)32;1-31-16-19(15-28-31)20-8-7-17(14-26-20)11-18-12-22(29-24(13-18)32-10-4-9-27-32)25(34)30-21-5-2-3-6-23(21)33;1-16-27-22(15-33-16)19-8-6-17(7-9-19)12-18-13-21(25(32)29-20-4-2-5-23(20)31)28-24(14-18)30-11-3-10-26-30/h4,7-12,14-16,21,24,32H,2-3,5-6,13H2,1H3,(H,30,33);4,7-10,12-16,21,23,33H,2-3,5-6,11H2,1H3,(H,30,34);3,6-11,13-15,20,23,31H,2,4-5,12H2,1H3,(H,29,32)/t21-,24-;21-,23-;20-,23-/m000/s1.
What are the key properties of N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide?
N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide has a molecular weight of 1358.58 g/mol, XLogP of 10.01, 18 rotatable bonds, 6 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclohexyl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(1S,2S)-2-hydroxycyclopentyl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide is sourced from PubChem (CID 158894627), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).